SI1227814T1 - Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof - Google Patents

Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof

Info

Publication number
SI1227814T1
SI1227814T1 SI200030615T SI200030615T SI1227814T1 SI 1227814 T1 SI1227814 T1 SI 1227814T1 SI 200030615 T SI200030615 T SI 200030615T SI 200030615 T SI200030615 T SI 200030615T SI 1227814 T1 SI1227814 T1 SI 1227814T1
Authority
SI
Slovenia
Prior art keywords
oestrogen
composition based
nomegestrol acetate
hormonal composition
hormonal
Prior art date
Application number
SI200030615T
Other languages
English (en)
Slovenian (sl)
Inventor
Jacques Le Clos De Cimiez Paris
Jean-Louis Thomas
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of SI1227814T1 publication Critical patent/SI1227814T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200030615T 1999-10-25 2000-10-24 Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof SI1227814T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002588 WO2001030356A1 (fr) 1999-10-25 1999-10-25 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
PCT/FR2000/002939 WO2001030357A1 (fr) 1999-10-25 2000-10-24 Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Publications (1)

Publication Number Publication Date
SI1227814T1 true SI1227814T1 (en) 2005-06-30

Family

ID=9542727

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030615T SI1227814T1 (en) 1999-10-25 2000-10-24 Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof

Country Status (27)

Country Link
US (2) US8168619B1 (xx)
EP (1) EP1227814B1 (xx)
JP (1) JP5036943B2 (xx)
KR (1) KR100623788B1 (xx)
CN (1) CN100553637C (xx)
AP (1) AP1625A (xx)
AT (1) ATE286400T1 (xx)
AU (1) AU777704B2 (xx)
BR (1) BRPI0014979B8 (xx)
CA (1) CA2389025C (xx)
CZ (1) CZ303248B6 (xx)
DE (1) DE60017281T2 (xx)
DK (1) DK1227814T3 (xx)
ES (1) ES2235967T3 (xx)
HK (1) HK1050472B (xx)
HU (1) HU229382B1 (xx)
IL (2) IL148953A0 (xx)
MX (1) MXPA02004084A (xx)
NO (1) NO327973B1 (xx)
NZ (1) NZ518145A (xx)
OA (1) OA12072A (xx)
PL (1) PL199848B1 (xx)
PT (1) PT1227814E (xx)
RU (1) RU2261106C2 (xx)
SI (1) SI1227814T1 (xx)
WO (2) WO2001030356A1 (xx)
ZA (1) ZA200203398B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
ATE350041T1 (de) 2001-05-18 2007-01-15 Pantarhei Bioscience Bv Pharmaceutishe zusammensetzung für die hormonersatztherapie
EP1390041B1 (en) 2001-05-23 2009-11-25 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
DE60223795T2 (de) 2001-05-23 2008-11-27 Pantarhei Bioscience B.V. Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption
DE60216630T2 (de) * 2001-11-15 2007-09-20 Pantarhei Bioscience B.V. Verwendung von östrogen in kombination mit progestogen für die hormonsubstitutiionstherapie
SI1511496T1 (sl) 2002-06-11 2007-04-30 Pantarhei Bioscience Bv Metoda zdravljenja ali prevencije imunsko mediiranih motenj in farmacevtska formulacija za njeno uporabo
AU2003274941A1 (en) 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
TW200404548A (en) * 2002-06-25 2004-04-01 Wyeth Corp Pharmaceutical composition containing cyclothiocarbamate derivatives in treatment of hormone-related conditions
CA2492287C (en) 2002-07-12 2011-12-13 Pantarhei Bioscience B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
AU2003274823A1 (en) 2002-10-23 2004-05-13 Pantarhei Bioscience B.V. Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
CA2674325A1 (en) 2007-01-08 2008-07-17 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
CN107007611B (zh) * 2017-06-02 2020-04-14 上海市计划生育科学研究所 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
DE3603644A1 (de) 1986-02-06 1987-08-13 Metabowerke Kg Spannfutter zum einspannen von bohrern oder schlagbohrern
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
DE3888269T2 (de) 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
FR2695826B1 (fr) 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5552394A (en) 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE69629702T2 (de) 1995-08-01 2004-06-17 Isis Pharmaceuticals, Inc., Carlsbad Liposomale oligonukleotidzusammensetzungen
US5888543A (en) 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
DE60218881T2 (de) * 2001-11-15 2007-12-20 Pantarhei Bioscience B.V. Verfahren zur vorbeugung oder behandlung von benignen gynäkologischen störungen
PE20081895A1 (es) 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Also Published As

Publication number Publication date
JP5036943B2 (ja) 2012-09-26
US9084796B2 (en) 2015-07-21
AP1625A (en) 2006-07-04
AU1032601A (en) 2001-05-08
NO20021949D0 (no) 2002-04-25
BR0014979A (pt) 2002-11-26
NZ518145A (en) 2005-01-28
IL148953A0 (en) 2002-11-10
BRPI0014979B8 (pt) 2021-05-25
DE60017281D1 (de) 2005-02-10
CN1382053A (zh) 2002-11-27
RU2261106C2 (ru) 2005-09-27
RU2002113652A (ru) 2004-03-27
NO327973B1 (no) 2009-11-02
DK1227814T3 (da) 2005-04-11
CA2389025C (fr) 2009-12-08
CN100553637C (zh) 2009-10-28
JP2003515531A (ja) 2003-05-07
DE60017281T2 (de) 2005-12-08
HK1050472A1 (en) 2003-06-27
CZ20021427A3 (cs) 2002-08-14
HUP0203721A2 (hu) 2003-03-28
HUP0203721A3 (en) 2003-07-28
MXPA02004084A (es) 2003-08-20
ES2235967T3 (es) 2005-07-16
HU229382B1 (hu) 2013-11-28
AU777704B2 (en) 2004-10-28
KR20020057979A (ko) 2002-07-12
US8168619B1 (en) 2012-05-01
BRPI0014979B1 (pt) 2016-08-02
WO2001030356A1 (fr) 2001-05-03
PT1227814E (pt) 2005-05-31
IL148953A (en) 2007-06-03
ATE286400T1 (de) 2005-01-15
PL199848B1 (pl) 2008-11-28
CZ303248B6 (cs) 2012-06-20
AP2002002475A0 (en) 2002-06-30
CA2389025A1 (fr) 2001-05-03
KR100623788B1 (ko) 2006-09-18
NO20021949L (no) 2002-04-25
PL356847A1 (en) 2004-07-12
WO2001030357A1 (fr) 2001-05-03
EP1227814B1 (fr) 2005-01-05
HK1050472B (zh) 2005-07-08
OA12072A (fr) 2006-05-04
US20130172300A1 (en) 2013-07-04
ZA200203398B (en) 2003-12-03
EP1227814A1 (fr) 2002-08-07

Similar Documents

Publication Publication Date Title
AU7957798A (en) Medical device for (in vivo) nitric oxide release
AU4498400A (en) Nb-ti-zr-mo alloys for medical and dental devices
HUP0104943A3 (en) Controlled release formulation comprising gnrh-ii and its use
HK1048637A1 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents.
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL175858A0 (en) Extended use combination comprising estrogens and progestins
IL152448A0 (en) 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
HK1210708A1 (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HK1050472B (zh) 基於醋酸諾美孕酮和雌激素的激素組合物及其用途
MXPA02003174A (es) Combinacion novedosa de loteprednol y antihistaminicos.
MXPA01010404A (es) Peptidos moduladores de adhesion y metodos para utilizarlos.
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
AU6590500A (en) Vegf-d and angiogenic use thereof
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU4655300A (en) Abbreviated condom device
HUP0200096A3 (en) Steroid sulfatase inhibitors and using the same
AU2841801A (en) Triazolotriazinones and the use thereof
ZA200006340B (en) Dhea composition and method.
AU4853801A (en) Medical combination comprising salmeterol and budesonide
AU4426801A (en) Composition based on sphingolipid and beta-hydroxy-acid for skin care
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU6835300A (en) Diagnostic kit and use thereof
AU6200399A (en) Avian pneumovirus vaccine and diagnostic agent